- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Distal-Less Homeobox 5 Antibody recognizes DLX5, a homeobox-containing transcription factor that directs gene expression during embryonic development and tissue differentiation. As a member of the distal-less family of developmental regulators, DLX5 controls transcriptional programs required for craniofacial patterning, skeletal formation, limb development, and the maturation of multiple epithelial and mesenchymal tissues. By binding specific DNA regulatory elements, DLX5 coordinates lineage commitment and cellular differentiation throughout development. Consequently, Distal-Less Homeobox 5 Antibody is widely used to investigate developmental gene regulation and tissue-specific differentiation pathways.
DLX5 is best known for its critical role in osteoblast differentiation and bone formation. It functions upstream of key osteogenic regulators, including RUNX2, and promotes the expression of genes required for extracellular matrix production and mineralization. DLX5 also contributes to tooth development, neural crest differentiation, inner ear morphogenesis, and bone morphogenetic protein signaling. Because of these diverse biological functions, Distal-Less Homeobox 5 Antibody is valuable for studies of skeletal biology, regenerative medicine, stem cell differentiation, and developmental signaling. Researchers also employ DLX-5 Antibody to investigate mechanisms governing lineage specification and tissue regeneration.
Altered DLX5 expression has been reported in several human malignancies, including breast, ovarian, lung, prostate, and endometrial cancers, where abnormal transcriptional regulation may contribute to tumor progression, proliferation, migration, and epithelial-to-mesenchymal transition. In addition, mutations or dysregulated expression of DLX5 have been associated with developmental abnormalities affecting craniofacial structures, hearing, and skeletal formation. These findings have expanded the use of Distal-Less Homeobox 5 Antibody in cancer biology, developmental genetics, and translational research aimed at understanding tissue-specific transcriptional control.
NSJ Bioreagents offers Distal-Less Homeobox 5 Antibody products validated for research applications to support reliable detection of DLX5 across multiple experimental platforms. Whether performing Western blotting, immunohistochemistry, immunofluorescence, immunoprecipitation, or flow cytometry, a well-validated DLX-5 Antibody enables accurate analysis of DLX5 expression and localization.
For additional antibodies targeting the DLX5, visit our DLX5 Antibody / Homeobox Transcription Factor Antibody page to explore complementary products, validation data, and application results.
Optimal dilution of the Distal-Less Homeobox 5 Antibody / DLX-5 Antibody should be determined by the researcher.
E. coli-derived recombinant human DLX-5 protein (amino acids M1-G228) was used as the immunogen for the Distal-Less Homeobox 5 Antibody.
After reconstitution, the Distal-Less Homeobox 5 Antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Distal-Less Homeobox 5 antibody, DLX-5 antibody, DLX5 antibody, Homeobox Protein DLX5 antibody, Distal-Less Related Homeobox 5 antibody, Homeobox Transcription Factor antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.